Suppression of Neurological Deterioration in the APP1.PSEN1/APOE4 Murine Model of Alzheimer's Disease by AAV-Mediated Expression of APOE2 Christchurch

被引：0
|
作者：
Gunaydin, Caner [1 ]
Lephart, Hailey C. [1 ]
Stiles, Katie M. [1 ]
Hackett, Neil R. [1 ]
Kaminsky, Stephen M. [1 ]
Sondhi, Dolan [1 ]
Crystal, Ronald G. [1 ]
机构：
[1] Weill Cornell Med, Dept Med Genet, New York, NY USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
816
引用
收藏
页码：402 / 403
页数：2
相关论文
共 50 条
  • [1] Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
    Huang, Yu-Wen Alvin
    Zhou, Bo
    Nabet, Amber M.
    Wernig, Marius
    Sudhof, Thomas C.
    [J]. JOURNAL OF NEUROSCIENCE, 2019, 39 (37): : 7408 - 7427
  • [2] Commentary: Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
    Dzianok, Patrycja
    Kublik, Ewa
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [3] Second Generation APOE2+APOE4- AAV-Mediated Gene Therapy for APOE Homozygotes at Risk for Alzheimer's Disease
    Montel, Rachel
    Frenk, Esther
    Crystal, Ronald G.
    Stiles, Katie M.
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 167 - 168
  • [4] Polygenic Risk Score Analysis of Alzheimer's Disease in Cases without APOE4 or APOE2 Alleles
    Escott-Price, V
    Myers, A.
    Huentelman, M.
    Shoai, M.
    Hardy, J.
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2019, 6 (01): : 16 - 19
  • [5] Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles
    V. Escott-Price
    A. Myers
    M. Huentelman
    M. Shoai
    John Hardy
    [J]. The Journal of Prevention of Alzheimer's Disease, 2019, 6 : 16 - 19
  • [6] Second Generation AAV-Mediated Gene Therapy to Mitigate Risk for Alzheimer's Disease in APOE4/4Homozygotes
    Montel, Rachel A.
    Frenk, Esther
    Crystal, Ronald G.
    Stiles, Katie M.
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 395 - 395
  • [7] The pattern of distribution of extracellular matrix in ApoE2, ApoE3 and ApoE4 astrocytes. Relevance for Alzheimer's disease
    Keable, A.
    O'Neill, R.
    Johnston, D.
    Weller, R.
    Smith, N.
    Carare, R.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2018, 44 : 18 - 19
  • [8] Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease
    Martiskainen, Henna
    Haapasalo, Annakaisa
    Kurkinen, Kaisa M. A.
    Pihlajamaki, Jussi
    Soininen, Hilkka
    Hiltunen, Mikko
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 781 - 794
  • [9] Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease
    Aleshkov, S
    Abraham, CR
    Zannis, VI
    [J]. BIOCHEMISTRY, 1997, 36 (34) : 10571 - 10580
  • [10] Novel AAV Constructs for Targeted ApoE2 Delivery Counteracts the Impact of ApoE4 Expression in Amyloid Deposition and Neuroinflammation in Mouse Model of Amyloidosis
    Keiser, Megan S.
    Jackson, Rosemary J.
    Meltzer, Jonah C.
    Fystrada, Dustin P.
    Holtzman, David M.
    Davidson, Beverly L.
    Hyman, Bradley T.
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 467 - 467
12345